Patent US3344410A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5380716A Expired / Lapsed US ⏱️ 0.0 years remaining

Sulfated polysaccharides as inhibitors of smooth muscle cell proliferation

Assignee: Glycomed Inc
•
Filing: 1992-12-28
•
Granted: 1995-01-10
•
Expires: 2012-12-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Highly sulfated oligosaccharides in the form of hexasaccharide and octasaccharide compounds which have antiproliferative activity with respect to smooth muscle cells are useful in treatment of conditions characterized by unwanted smooth muscle cell proliferation such as a result of trauma or disease states such as asthma, congestive heart failure and hypertension. The oligosaccharides have increased ability to inhibit the proliferation of smooth muscle cells and decreased ability to act as an anticoagulant as compared with commercial heparin and/or unseparated fragments of heparin.

Inventors

  • 👤 H. Edward Conrad
  • 👤 Peter Fugedi
  • 👤 Brian K. Brandley
  • 👤 Lun H. Lam
  • 👤 Roger A. Laine

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 05:30
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/70; A61K31/715; C; C07; C07H; C07H11/00; C07H13/00; C07H13/02; C07H13/04; C07H17/00; C07H17/02; C07H17/04; C07H3/00; C07H3/06; C08; C08B; C08B37/00; C08B37/006; C08B37/0063; C08B37/0075; C08B37/0078

Claims Analysis

Total Claims: 20
Claim 1
Independent Claim 197 words
A compound that inhibits the proliferation of smooth muscle cells to a greater extent than commercial heparin, and has a decreased ability to act as an anticoagulant as compared to commercial heparin, the compound having the following structural formula: ##STR14## wherein each of A, B, C, and D is independently H or SO 3 R and each R is independently H or a cation, with the proviso that at least two of A, B, C or D is --SO 3 R; noting that hydroxyl groups on the sugars have been omitted in Formulas I and I(a) for greater clarity and the * adjacent the carbon substituted with COOH indicates any possible stereochemistry in either I or I(a); R 1 and R 2 are each independently hydrogen or a unit having the following structure: ##STR15## wherein when a unit of Formula I(a) is connected at one end, the hydrogen at that end is not present; and each of E and F is independently hydrogen or SO 3 R and noting that the hydroxyl group on the 3-position on each sugar is present but has been omitted for greater clarity and further noting that the 3-position is not sulfated.
Claim 2
Dependent Claim 197 words
A compound that inhibits the proliferation of smooth muscle cells to a greater extent than commercial heparin, and has a decreased ability to act as an anticoagulant as compared to commercial heparin, the compound having the following structural formula: ##STR14## wherein each of A, B, C, and D is independently H or SO 3 R and each R is independently H or a cation, with the proviso that at least two of A, B, C or D is --SO 3 R; noting that hydroxyl groups on the sugars have been omitted in Formulas I and I(a) for greater clarity and the * adjacent the carbon substituted with COOH indicates any possible stereochemistry in either I or I(a); R 1 and R 2 are each independently hydrogen or a unit having the following structure: ##STR15## wherein when a unit of Formula I(a) is connected at one end, the hydrogen at that end is not present; and each of E and F is independently hydrogen or SO 3 R and noting that the hydroxyl group on the 3-position on each sugar is present but has been omitted for greater clarity and further noting that the 3-position is not sulfated.
Claim 3
Dependent Claim 19 words
The compound of claim 1, wherein at least three of A, B, C or D are --SO 3 R.
Claim 4
Dependent Claim 17 words
The compound of claim 2, wherein all of A, B, C and D are --SO 3 R.
Claim 5
Dependent Claim 31 words
The compound of claim 1, wherein R 1 and R 2 are H, and each R is H, ----Na + , K + , Ca 2+ or NH 4 + ----.
Claim 6
Dependent Claim 138 words
A hexasaccharide and octasaccharide compound that inhibits the proliferation of smooth muscle cells to a greater extent than commercial heparin, and has a decreased ability to act as an anticoagulant as compared to commercial heparin, the compound having the following structural formula: ##STR16## wherein n is 1 or 2 and each of A, B, C and D is independently H or SO 3 R, wherein each R is independently H or a cation, with the proviso that at least two of said A, B, C and D are SO 3 R; and wherein a hydroxyl group present on the 3 position of each sugar is present but has been omitted from the depiction; and noting that the 3-position is not sulfated; and wherein the asterisk on the carbons substituted with carboxyl indicates that the stereochemistry is not determined.
Claim 7
Dependent Claim 138 words
A hexasaccharide and octasaccharide compound that inhibits the proliferation of smooth muscle cells to a greater extent than commercial heparin, and has a decreased ability to act as an anticoagulant as compared to commercial heparin, the compound having the following structural formula: ##STR16## wherein n is 1 or 2 and each of A, B, C and D is independently H or SO 3 R, wherein each R is independently H or a cation, with the proviso that at least two of said A, B, C and D are SO 3 R; and wherein a hydroxyl group present on the 3 position of each sugar is present but has been omitted from the depiction; and noting that the 3-position is not sulfated; and wherein the asterisk on the carbons substituted with carboxyl indicates that the stereochemistry is not determined.
Claim 8
Dependent Claim 19 words
A compound of claim 5, wherein at least three of A, B, C or D are --SO 3 R.
Claim 9
Dependent Claim 19 words
A compound of claim 5, wherein at least four of A, B, C or D are --SO 3 R.
Claim 10
Dependent Claim 19 words
A compound of claim 5, wherein at least five of A, B, C or D are --SO 3 R.
Claim 11
Dependent Claim 17 words
A compound of claim 5, wherein all of A, B, C and D are --SO 3 R.
Claim 12
Dependent Claim 22 words
A compound of claim 5, wherein each R is H,----Na + , K + , Ca 2+ or NH 4 + ----.
Claim 13
Dependent Claim 138 words
A hexasaccharide and octasaccharide compound that inhibits the proliferation of smooth muscle cells to a greater extent than commercial heparin, and has a decreased ability to act as an anticoagulant as compared with commercial heparin the compound having the following structural formula: ##STR17## wherein n is 1 or 2 and each of A, B, C and D is independently H or SO 3 R, wherein each R is independently H or a cation, with the proviso that at least two of said A, B, C and D are SO 3 R; and wherein a hydroxyl group present on the 3 position of each sugar is present but has been omitted from the depiction and noting that the 3-position is not sulfated; and wherein the asterisk on the carbons substituted with carboxyl indicates that the stereochemistry is not determined.
Claim 14
Dependent Claim 138 words
A hexasaccharide and octasaccharide compound that inhibits the proliferation of smooth muscle cells to a greater extent than commercial heparin, and has a decreased ability to act as an anticoagulant as compared with commercial heparin the compound having the following structural formula: ##STR17## wherein n is 1 or 2 and each of A, B, C and D is independently H or SO 3 R, wherein each R is independently H or a cation, with the proviso that at least two of said A, B, C and D are SO 3 R; and wherein a hydroxyl group present on the 3 position of each sugar is present but has been omitted from the depiction and noting that the 3-position is not sulfated; and wherein the asterisk on the carbons substituted with carboxyl indicates that the stereochemistry is not determined.
Claim 15
Dependent Claim 19 words
A compound of claim 11, wherein at least three of A, B, C or D are --SO 3 R.
Claim 16
Dependent Claim 19 words
A compound of claim 11, wherein at least four of A, B, C or D are --SO 3 R.
Claim 17
Dependent Claim 19 words
A compound of claim 11, wherein at least five of A, B, C or D are --SO 3 R.
Claim 18
Dependent Claim 17 words
A compound of claim 11, wherein all of A, B, C and D are --SO 3 R.
Claim 19
Dependent Claim 23 words
A compound of claim 11, wherein each R is H, ----Na + , K + , Ca 2+ or NH 4 + ----.
Claim 20
Dependent Claim 76 words
A pharmaceutical composition that inhibits unwanted smooth muscle cell proliferation, comprising: a pharmaceutically effective amount of a heparin digest derivative in the form of oligosaccharide fragments selected from the group consisting of a hexasaccharide or octasaccharide compound of claim 5 or pharmaceutically acceptable salts thereof which fragments have an increased ability to inhibit smooth muscle cell proliferation and a decreased ability to act as an anticoagulant as compared with commercial heparin; and a pharmaceutically acceptable carrier.

References Cited (Backward Citations)

US4401662A Cited
US4943630A Cited
US5019562A Cited
US5032679A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1998-01-09 1998-07-11 1999-01-10 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2002-01-09 2002-07-11 2003-01-10 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2006-01-09 2006-07-11 2007-01-10 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag